Neurometrix Inc
(NURO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,766 | -8,019 | -10,008 | -9,981 | -16,891 |
| Depreciation Amortization | 145 | 151 | 297 | 377 | 524 |
| Accounts receivable | -189 | 176 | 343 | 683 | 1,734 |
| Accounts payable and accrued liabilities | 200 | 66 | -372 | 370 | -828 |
| Other Working Capital | 652 | 250 | -19 | 1,698 | -200 |
| Other Operating Activity | -720 | 822 | 583 | 75 | 2,354 |
| Operating Cash Flow | $-7,679 | $-6,555 | $-9,176 | $-6,778 | $-13,307 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -227 | -86 | -108 | -111 | -307 |
| Sale Of Investment | N/A | N/A | N/A | N/A | 7,495 |
| Other Investing Activity | 0 | 0 | 230 | 179 | 0 |
| Investing Cash Flow | $-227 | $-86 | $122 | $68 | $7,189 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | -18 | -20 | -19 | -28 |
| Common Stock Issued | 7,932 | 7,155 | 7,483 | 34 | 196 |
| Financing Cash Flow | $7,932 | $7,137 | $7,463 | $15 | $168 |
| Beginning Cash Position | 9,196 | 8,700 | 10,291 | 16,987 | 22,937 |
| End Cash Position | 9,222 | 9,196 | 8,700 | 10,291 | 16,987 |
| Net Cash Flow | $26 | $496 | $-1,591 | $-6,696 | $-5,951 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,679 | -6,555 | -9,176 | -6,778 | -13,307 |
| Capital Expenditure | -227 | -86 | -108 | -111 | -307 |
| Free Cash Flow | -7,906 | -6,641 | -9,283 | -6,889 | -13,614 |